Table 6.
Human intervention studies using fermented foods containing synbiotics.
Food matrix | Probiotic/s and prebiotic/s | Administered daily amount and duration of treatment | Food intake evaluation | Study design | Subjects main characteristics | Effects on gut microbiota | Gut microbiota analysis methods and microbial groups analyzed | Colonization evaluation | Persistence evaluation | Methods of analysis for colonization | References |
---|---|---|---|---|---|---|---|---|---|---|---|
Fermented milk (Control: fermented milk without probiotics and prebiotics) | Lactobacillusarhamnosus IMC 501® and L.a paracasei IMC 502® + oat bran fiber | 200 g containing 1 × 109 CFU for each strain + 8 g oat bran fiber, for 4 weeks | No | Double blind randomized placebo controlled trial (n = 10, 5 treated and 5 placebo) | Italian healthy adults (3 men and 7 women); age range 20–45 years | Lactobacilli and Bifidobacteria increased, no differences for the other groups | qPCR for Lactobacillus spp., Bifidobacterium spp., Enterobacteriaceae, Clostridium coccoides-Eubacterium rectale group, Staphylococcus spp., Bacteroides-Prevotella-Porphyromonas spp | No | – | – | (65) |
Fermented milk (Control: heat-treated fermented milk without probiotics and fibers) | L. acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 + dietary fiber Beneo Orafti Synergy 1 (90% inulin, 10% oligofructose) | 180 g containing on average 6.5 × 109 CFU La-5 and 9 × 109 CFU BB-12 + 7.2 g dietary fiber, for 4 weeks | No | Double blind randomized placebo-controlled multicentric trial with 2 weeks pre-intervention washout and 1 week post-intervention washout (n = 30, 11 treated and 19 placebo) | Slovenian and Croatian adults with IBS; age range 18–65 years | The abundance or proportion of Enterobacteriaceae, Lactobacillus, Bifidobacterium, or all bacteria was not affected by consumption of the synbiotic or placebo, except for a transient increase of Streptococcus thermophilus
Both La-5 and BB-12 strains colonized, but vitality of La-5 was not confirmed. Persistence was not found |
qPCR for Enterobacteriaceae, Bifidobacterium genus, Lactobacillus group, all bacteria 16S rRNA based metagenomics: V4 variable region of 16S rRNA gene (All bacteria) |
Yes | Yes | Strain and subspecies-specific qPCR for La-5 and B. animalis subsp. lactis. RAPD-PCR profiling of cultured colonies for La-5 and BB-12 vitality | (66) |
Yogurt | L.arhamnosus GR-1 + Moringa oleifera leaves | 250 g containing 1 × 1010 CFU GR-1 + 4.3 g dried ground Moringa oleifera leaves. 6 days/week from time of recruitment (last 2 trimesters) until exiting the study (1 week to 1 month postpartum). Mean of treatment duration: 88 days ± 31 | 48 h dietary recall | Open label trial (n=56, 26 treated and 30 control) Longitudinal over pregnancy and after delivery | Tanzanian pregnant women; age range 18–40 years | Yogurt consumption had no effect on the mother's microbiota (but increased the relative abundance of Bifidobacterium and decreased Enterobacteriaceae in the newborn feces). No clear trend was detected when comparing probiotic to control groups | 16S rRNA based metagenomics: V4 variable region of 16S rRNA gene (All bacteria) | No | – | – | (67) |
Yogurt GRANAROLO ViviVivo (Control: pasteurized yogurt without probiotics and prebiotics) | L.arhamnosus GG (LGG) + FOS-Actilight | 250 g containing approximately 2.5 × 109 CFU LGG + 6 g FOS, for 4 weeks | No | Adults: double blind randomized placebo-controlled trial with 2 weeks post-intervention washout (n = 38, 21 treated and 17 placebo). Elderly: Before-After trial with 2 weeks post-intervention washout (n = 12) | Two independent studies: Italian healthy adults (19 men and 19 women); age range 35–60 years, and elderly women with constipation, age range 76–90 years | No significant changes in bifidobacteria counts and Bifidobacterium spp. abundance were observed after supplementation, both in elderly and treated adults. LGG was able to colonize and persisted after washout in adults, whereas it only partially colonized and did not persist in elderly |
Semi-quantitative PCR for total Bifidobacteria and for the 4 Bifidobacterium species: B. bifidum, B. longum, B. adolescentis and B. catenulatum | Yes | Yes | Semi-quantitative LGG strain-specific PCR | (68) |
Fermented milk | L. acidophilus CSG, L.b brevis HY7401, Bifidobacterium longum HY8001, L.a casei HY2782 + fiber + lactulose | 140 g containing 2.8 × 1010 CFU Lactobacillus + 6 g dietary fiber + 2 g lactulose, for 3 weeks | No | Before-After trial with 3 weeks post-intervention washout (n = 6) | Korean healthy adult women; age range 20-24 years | Relative abundance of Bacteroidetes (Bacteroidaceae and Prevotellaceae) increased during the treatment period and decreased during washout. Firmicutes (Ruminococcaceae and Lachnospiraceae) changed in the opposite way | 16S rRNA based metagenomics: V1–V3 variable region of 16S rRNA gene (All bacteria) | No | – | – | (69) |
Recently renamed Lacticaseibacillus.
Recently renamed Levilactobacillus.